Alector alector.com


Public list: Pharma Startups (4732) Google In Healthcare (60)

Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is combining antibody technology and recent discoveries in neuro-immunology and human genetics to develop a platform of therapeutics that harness the immune system to fight dementia and neurodegeneration.

Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is combining antibody technology and recent discoveries ...Show all

Company (Alive / Active)

All investors data 22 Investors

Phone: 415-231-5660

Fax:

151 Oyster Blvd
Suite 300
 South San Francisco, 94080
 California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alector $194.5M Jul 25, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alector Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors

Board Members

Name Firm
Login to see detailsOrbiMed Advisors
Login to see detailsPolaris Partners
Login to see detailsSV Health Investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-apoe4 antigen-binding proteins and methods of use thereof Jan 25, 2017 Application
Anti-sortilin antibodies and methods of use thereof Oct 04, 2016 Application
Anti-trem2 antibodies and methods of use thereof Aug 08, 2015 Application